Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Bio-Rad Laboratories stock

Learn how to easily invest in Bio-Rad Laboratories stock.

Bio-Rad Laboratories Inc is a medical devices business based in the US. Bio-Rad Laboratories shares (BIO) are listed on the NYSE and all prices are listed in US Dollars. Bio-Rad Laboratories employs 7,900 staff and has a trailing 12-month revenue of around $2.9 billion.

How to buy shares in Bio-Rad Laboratories

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BIO – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Bio-Rad Laboratories stock price (NYSE: BIO)

Use our graph to track the performance of BIO stocks over time.

Bio-Rad Laboratories shares at a glance

Information last updated 2022-10-02.
Latest market close$417.14
52-week range$406.24 - $798.97
50-day moving average $497.22
200-day moving average $552.60
Wall St. target price$703.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-3.39

Buy Bio-Rad Laboratories shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Bio-Rad Laboratories stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Bio-Rad Laboratories price performance over time

Historical closes compared with the close of $417.14 from 2022-09-30

1 week (2022-09-27) 1.10%
1 month (2022-09-02) -12.79%
3 months (2022-07-01) -16.96%
6 months (2022-04-01) -26.93%
1 year (2021-10-01) -43.78%
2 years (2020-10-02) -18.32%
3 years (2019-10-04) 22.92%
5 years (2017-10-04) 85.09%

Is Bio-Rad Laboratories stock undervalued or overvalued?

Valuing Bio-Rad Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Bio-Rad Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Bio-Rad Laboratories's PEG ratio

Bio-Rad Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0737. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Bio-Rad Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Bio-Rad Laboratories's EBITDA

Bio-Rad Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $725.6 million.

The EBITDA is a measure of a Bio-Rad Laboratories's overall financial performance and is widely used to measure a its profitability.

Bio-Rad Laboratories financials

Revenue TTM $2.9 billion
Operating margin TTM 20.68%
Gross profit TTM $1.7 billion
Return on assets TTM 2.67%
Return on equity TTM -18.93%
Profit margin -67.66%
Book value $300.45
Market capitalisation $12.4 billion

TTM: trailing 12 months

Bio-Rad Laboratories's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Bio-Rad Laboratories.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Bio-Rad Laboratories's total ESG risk score

Total ESG risk: 23.57

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Bio-Rad Laboratories's overall score of 23.57 (as at 12/31/2018) is pretty good – landing it in it in the 28th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Bio-Rad Laboratories is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Bio-Rad Laboratories's environmental score

Environmental score: 6.03/100

Bio-Rad Laboratories's environmental score of 6.03 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Bio-Rad Laboratories is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Bio-Rad Laboratories's social score

Social score: 16.8/100

Bio-Rad Laboratories's social score of 16.8 puts it squarely in the 6th percentile of companies rated in the same sector. This could suggest that Bio-Rad Laboratories is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Bio-Rad Laboratories's governance score

Governance score: 10.75/100

Bio-Rad Laboratories's governance score puts it squarely in the 6th percentile of companies rated in the same sector. That could suggest that Bio-Rad Laboratories is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Bio-Rad Laboratories's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Bio-Rad Laboratories scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Bio-Rad Laboratories has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Bio-Rad Laboratories Inc was last rated for ESG on: 2019-01-01.

Total ESG score 23.57
Total ESG percentile 27.74
Environmental score 6.03
Environmental score percentile 6
Social score 16.8
Social score percentile 6
Governance score 10.75
Governance score percentile 6
Level of controversy 2

Bio-Rad Laboratories share dividends

We're not expecting Bio-Rad Laboratories to pay a dividend over the next 12 months.

Have Bio-Rad Laboratories's shares ever split?

Bio-Rad Laboratories's shares were split on a 2:1 basis on 7 March 2002. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Bio-Rad Laboratories shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Bio-Rad Laboratories shares which in turn could have impacted Bio-Rad Laboratories's share price.

Bio-Rad Laboratories share price volatility

Over the last 12 months, Bio-Rad Laboratories's shares have ranged in value from as little as $406.24 up to $798.97. A popular way to gauge a stock's volatility is its "beta".

BIO.US volatility(beta: 0.99)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Bio-Rad Laboratories's is 0.9856. This would suggest that Bio-Rad Laboratories's shares are less volatile than average (for this exchange).

Bio-Rad Laboratories overview

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market.

Frequently asked questions

What percentage of Bio-Rad Laboratories is owned by insiders or institutions?
Currently 14.463% of Bio-Rad Laboratories shares are held by insiders and 79.664% by institutions.
How many people work for Bio-Rad Laboratories?
Latest data suggests 7,900 work at Bio-Rad Laboratories.
When does the fiscal year end for Bio-Rad Laboratories?
Bio-Rad Laboratories's fiscal year ends in December.
Where is Bio-Rad Laboratories based?
Bio-Rad Laboratories's address is: 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547
What is Bio-Rad Laboratories's ISIN number?
Bio-Rad Laboratories's international securities identification number is: US0905722072
What is Bio-Rad Laboratories's CUSIP number?
Bio-Rad Laboratories's Committee on Uniform Securities Identification Procedures number is: 090572207

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site